Pacliget 30mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is Paclitaxel, a potent chemotherapy agent that works by disrupting the normal function of microtubules within cancer cells. Microtubules are essential for cell division, and by interfering with their assembly and disassembly, Pacliget effectively halts the proliferation of cancerous cells. This mechanism of action makes it a valuable tool in combating various malignancies.
Pacliget 30mg Injection is indicated for the treatment of advanced ovarian cancer, breast cancer, and non-small cell lung cancer. The dosage and administration schedule are determined by the treating physician based on the specific type and stage of cancer, as well as the patient’s overall health and response to treatment. It is typically administered intravenously.
Common side effects associated with Pacliget 30mg Injection may include bone marrow suppression (leading to low blood cell counts), hair loss, nerve damage (neuropathy), nausea, vomiting, diarrhea, and allergic reactions. Patients should be closely monitored by their healthcare provider during treatment. Pacliget 30mg Injection should be stored at room temperature, protected from light, and should not be frozen.
